Anuh Pharma Stock

Anuh Pharma Equity

The The Equity of Anuh Pharma (ANUHPHR.NS) as of Aug 26, 2026 is 3.26 B INR. In the previous year, The Equity was 2.91 B INR — a change of 11.95% (higher).

Equity

3.26 BINR

YoY

11.95%

Last updated:

In 2026, Anuh Pharma's equity was 3.26 B INR, a 11.95% increase from the 2.91 B INR equity in the previous year.

The Anuh Pharma Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
1.50 B INR
Jan 1, 2019
1.65 B INR
Jan 1, 2020
1.62 B INR
Jan 1, 2021
1.91 B INR
Jan 1, 2022
2.14 B INR
Jan 1, 2023
2.41 B INR
Jan 1, 2024
2.91 B INR
Jan 1, 2025
3.26 B INR
The Anuh Pharma Equity history
YEAREquityYoY
3.26 BINR+11.95%
2.91 BINR+20.73%
2.41 BINR+12.84%
2.14 BINR+12.13%
1.91 BINR+17.53%
1.62 BINR-1.46%
1.65 BINR+10.02%
1.50 BINR+6.45%
1.41 BINR+15.10%
1.22 BINR+21.02%
1.01 BINR—
Access this data via the Eulerpool API
Get Free API Key

Anuh Pharma Stock analysis

What does Anuh Pharma do? Anuh Pharma is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Anuh Pharma's Equity

Anuh Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Anuh Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Anuh Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Anuh Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Anuh Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Anuh Pharma stock

The Equity of Anuh Pharma is 3.26 B INR in 2026.

The Equity of Anuh Pharma changed from 2.91 B INR to 3.26 B INR, representing a 11.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Anuh Pharma since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Anuh Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Anuh Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Anuh Pharma